尾加压素Ⅱ及其在缺血-再灌注损伤中的作用
摘要
尾加压素Ⅱ(UⅡ)参与器官的缺血-再灌注损伤的病理生理过程,但其机制仍未阐明。本文就UⅡ的结构、分布、生物学效应及在器官缺血-再灌注损伤中的作用作一综述。
出处
《汕头大学医学院学报》
2008年第1期52-54,共3页
Journal of Shantou University Medical College
参考文献23
-
1Coulouarn y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotenin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord[J]. Proc Natl Aead Sci USA, 1998, 95 (26) : 15 803 - 15 808.
-
2Ames RS, Saran HM, Chambers JK, et al. Human urotensin Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature, 1999, 401(6 750) : 282 - 286.
-
3Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J] . Exp Zool, 1996, 275(2-3): 226- 238.
-
4Brkovic A, Hattenberger A, Kostenis E, et al. Functional and binding characterizations of urotensinⅡ-related peptides in human and rat urotensin Ⅱ-receptor assay[J]. Pharmacol Exp Ther, 2003, 306(3) : 1 200 - 1 209.
-
5Boucard AA, Tauve SS, Guillemette G, et al. Photolabelling the rat urotensin Ⅱ/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain[J]. Biochem J, 2003, 370(Pt3) : 829 - 838.
-
6Hubbard R, Johnston I, Britton J. Survival in patients with crypto-genic fihro singal veolitis: apopulation-based cohort study[J]. Chest, 1998, 113(2): 396-400.
-
7Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin Ⅱ: receptor localization in Human tissues and comparison of vasoconstric to responses with endothlin-1 [ J ]. Br J Qharmacol, 2000, 131(3): 441-446.
-
8Maclean MR, Alexander D, Stirrat A, et al. Contractile responses to human urotensin- Ⅱ in rat and human pulmonary arterise: effect to fendothelial factors and chronic hypoxia in the rat[J]. Br J Pharmacol, 2000, 130(2) : 201 - 204.
-
9Gibson A, Conyers S, Bern HA. The influence of urotensin Ⅱ on calcium flux in rat aorta[J]. J Pharmacol, 1988, 40(12) : 893 - 895.
-
10Wang YX, Ding YJ, Zhu YZ, et al. Role of PKC in the novel synergistic action of urotcnsin Ⅱ and angiotcnsin Ⅱ and in urotensin Ⅱ-induced vasoconstriction[J]. Am J Physiol Heart Circ Physiol, 2007, 292(1) : H348 - 359.
二级参考文献42
-
1张勇刚 杨军 等.尾加压素II在心血管系统中的作用[J].北京医科大学学报,2000,32(2):133-133.
-
2Merin RG. The isolated heart preparation. Br J Anaesth 1988, 60(8 Suppl 1):28S-34S.
-
3Elz JS, Nayler WG. Quantification of calcium paradox in neonatal rat hearts. Am J Physiol 1987;253(6 Pt 2):H1358 - H1364.
-
4Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 ;95(2) :351 -358.
-
5Itoh H, McMaster D, Lederis K. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol 1988 ;149(1-2) :61 -66.
-
6Zhang Y, Li J, Cao J, Chen J, Yang J, Zhang Z, Du J,Tang C. Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium. Heart Vessels 2002;16(2) :64 -68.
-
7Moore G, Letter A, Tesanovic M, Lederis K. Studies on molecular weights d two peptide hormones from the urophysis of white sucker ( Catostomus commersoni ). Can J Biochem 1975 ;53 (2) : 242 - 247.
-
8Coulouam Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillaln JC, Cordon JM, Bern HA, Vaudry R.Cloning of the cDNA encoding the urotensin lI precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 1998;95(26) :15803 -15808.
-
9Coulouarn Y, Jegou S, Tostivint H, Vaudry H, Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 1999:457( 1 ):28 - 32.
-
10Ames RS, Sarau HM, Chambers ,JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ,Hay DW, Douglas SA. Human urotensin-II : a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999;401(6750):282-286.
共引文献57
-
1Lifang Zhang Yuannan Ke Yong Wang Xianlun Li Li Chen.Association of urotensin Ⅱ with angiographic severity of coronary artery disease[J].Journal of Geriatric Cardiology,2007,4(4):229-232.
-
2左辉华,洪介民,郭衡山,韦建瑞,何艳华,李志樑.尾加压素Ⅱ诱导体外培养的乳鼠心肌细胞肥大的研究[J].第一军医大学学报,2004,24(6):642-645. 被引量:2
-
3钟亮尹,朱桂平,曾智华.鼠尾加压素ⅡELISA检测方法的建立及临床意义[J].广西医学,2004,26(7):949-951.
-
4朱桂平,钟亮尹,周万兴,靳晨亭,曾智桓,张卫,刘群峰.幼龄自发性高血压大鼠血浆尾加压素Ⅱ的变化及负荷运动对它的影响[J].中国心血管病研究,2004,2(9):731-733. 被引量:3
-
5窦丽,陈华卫,张钧.尾加压素Ⅱ与心血管疾病[J].心血管病学进展,2004,25(6):423-425.
-
6裴海成,李明子.尾加压素Ⅱ与糖尿病及肾脏疾病[J].中华医学杂志,2005,85(14):1003-1005. 被引量:1
-
7郭艳红,汪长华.尾加压素Ⅱ及其对心脏的调控作用[J].中国心脏起搏与心电生理杂志,2005,19(2):153-154. 被引量:2
-
8吴美善,金海.尾加压素Ⅱ与心血管疾病的研究进展[J].延边大学医学学报,2005,28(3):220-223.
-
9王慧卿,蒋绿芝.尾加压素Ⅱ与2型糖尿病关系的研究进展[J].国外医学(内分泌学分册),2005,25(6):417-419. 被引量:1
-
10丁波,高杉,陈志武.人UrotensinⅡ在心血管系统中的生物学效应[J].中国临床药理学与治疗学,2005,10(11):1210-1214. 被引量:2
-
1赵大华.一氧化碳生理作用研究进展[J].临床荟萃,2002,17(9):553-554.
-
2郝增涛,冯卫,郝廷,余斌.不同比例共培养内皮细胞和成骨细胞的成骨及成血管效应[J].中国组织工程研究,2012,16(20):3616-3619.
-
3李慧丽,黄定九.胰岛素的血管效应和内皮功能[J].心脏杂志,2000,12(1):40-42.
-
4闫辉,杜军保,唐朝枢.硫化氢对自发性高血压大鼠胸主动脉舒张反应的影响[J].中国药理学通报,2003,19(6):633-636. 被引量:22
-
5孙英伦,杨镛.SDF-1/CXCR4轴及其抑制剂AMD3100调控Tip内皮细胞成血管效应的研究进展[J].中外医学研究,2017,15(5):160-162.
-
6于翔,李珍,王海亮,周及彤,张维,魏健,徐永强,刘军.NO的合成和NO的血管效应[J].中国老年学杂志,2013,33(1):232-234. 被引量:2
-
7血红素加氧酶-2和大电导Ca^2+激活的K^+通道:缺氧时的肺血管效应[J].中华医学信息导报,2009,24(13):13-13.
-
8杜玲娟,杨镛.SDF-1/CXCR4调控Tip内皮细胞成血管效应的研究进展[J].中国血管外科杂志(电子版),2011,3(3):191-194. 被引量:2
-
9槐勇,王跃民,马恒,孙新,毕辉,张鹏,裴建明.U50,488H对大鼠肾动脉的舒张作用及其机制[J].第四军医大学学报,2004,25(23):2121-2123.
-
10夏保芦,艾永循,杨荣.TRH在蓝斑复合核的呼吸和心血管效应与延髓头端腹外侧区的关系[J].湖北中医学院学报,2001,3(2):49-51. 被引量:1